Affymetrix last week announced a record year financially, hitting GAAP profitability while recording $300 million in total revenues for the fiscal year ending on Dec. 31, and then saying that it expects FY ‘04 to be even better.

“2003 was a transformational year: In less than a decade after founding the company, we achieved record product and product-related revenue,” Steve Fodor, Affymetrix chairman and chief executive officer, said in last week’s conference call announcing the results. “We remain focused on growing the business and increasing profits.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.